S269: MALE PATIENTS WITH SCD HAVE A HIGHER RISK OF CEREBROVASCULAR DISEASE, INCREASED INFLAMMATORY MARKERS, AND POORER RESPONSE TO HYDROXYUREA
Margherita DI Mauro,
Amina Nardo‐marino,
Sara Stuart-Smith,
Sara El Hoss,
John Strouboulis,
Stephan Menzel,
John Gibson,
David Rees,
John Brewin
Affiliations
Margherita DI Mauro
1 King’s College Hospital, Department of Haematological Medicine, London, United Kingdom
Amina Nardo‐marino
1 King’s College Hospital, Department of Haematological Medicine, London, United Kingdom
Sara Stuart-Smith
1 King’s College Hospital, Department of Haematological Medicine, London, United Kingdom
Sara El Hoss
2 King’s College London, Red Cell Haematology Laboratory, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, London, United Kingdom
John Strouboulis
2 King’s College London, Red Cell Haematology Laboratory, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, London, United Kingdom
Stephan Menzel
2 King’s College London, Red Cell Haematology Laboratory, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, London, United Kingdom
John Gibson
5 University of Cambridge, Department of Veterinary Medicine, Cambridge, United Kingdom
David Rees
1 King’s College Hospital, Department of Haematological Medicine, London, United Kingdom
John Brewin
1 King’s College Hospital, Department of Haematological Medicine, London, United Kingdom
